Kathleen Tregoning - Insider Trading & Ownership

Location
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, MA
Summary
The estimated net worth of Kathleen Tregoning is at least $54.8K dollars as of June 16, 2025. Kathleen Tregoning is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $54.8K.
Signature
/s/ Maegan Deare, Attorney-in-Fact for Kathleen Tregoning
All Insider Reports
All Insider Reports

Notify me when Kathleen Tregoning files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kathleen Tregoning

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRO Spero Therapeutics, Inc. Director $54.8K Jun 12, 2025
CERE Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer $0 Aug 1, 2024

Insider Transactions Reported by Kathleen Tregoning:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.